These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5902917)

  • 1. Decrease of ethanol-induced fatty liver by ethyl alpha-p-chlorophenoxyisobutyrate.
    Spritz N; Lieber CS
    Proc Soc Exp Biol Med; 1966 Jan; 121(1):147-9. PubMed ID: 5902917
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of ethyl alpha-p. chlorophenoxyisobutyrate on ethanol-induced hepatic steatosis in the rat.
    Brown DF
    Metabolism; 1966 Oct; 15(10):868-73. PubMed ID: 5923523
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of ethyl chlorophenoxyisobutyrate (CPIB) on the uptake of triglyceride fatty acids, activity of lipoprotein lipase and lipogenesis from glucose in fat tissue of rats.
    Nestel PJ; Austin W
    J Atheroscler Res; 1968; 8(5):827-33. PubMed ID: 5688379
    [No Abstract]   [Full Text] [Related]  

  • 4. The mechanisms underlying the hypolipidaemic effects of atromid S, nicotinic acid and benzalecene. I. The metabolism of free fatty acid-albumin complex by the isolated perfused liver.
    Mishkel MA; Webb WF
    Biochem Pharmacol; 1967 May; 16(5):897-905. PubMed ID: 6036737
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of ethylchlorophenoxyisobutyrate on weight, plasma volume, total body-water, and free fatty acids.
    Macmillan DC; Oliver MF; Simpson JD; Tothill P
    Lancet; 1965 Nov; 2(7419):924-6. PubMed ID: 4165275
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of liver and adipose tissue in the pathogenesis of the ethanol-induced fatty liver.
    Poggi M; Di Luzio NR
    J Lipid Res; 1964 Jul; 5(3):437-41. PubMed ID: 5873384
    [No Abstract]   [Full Text] [Related]  

  • 7. Increase of hepatic mitochondria on administration of ethyl alpha-p-chlorophenoxyisobutyrate to the rat.
    Kurup CK; Aithal HN; Ramasarma T
    Biochem J; 1970 Mar; 116(5):773-9. PubMed ID: 5441366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the weight and composition of the liver in the rat, dog and monkey treated with ethyl chlorophenoxyisobutyrate.
    Platt DS; Thorp JM
    Biochem Pharmacol; 1966 Jul; 15(7):915-25. PubMed ID: 4961207
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of chlorophenoxyisobutyrate on the metabolism of endogenous glycerides in man.
    Sodhi HS; Kudchodkar BJ; Horlick L
    Metabolism; 1971 Mar; 20(3):309-18. PubMed ID: 5546926
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes in the liver concentrations of the nicotinamide adenine dinucleotide coenzymes and in the activities of oxidoreductase enzymes following treatment of the rat with ethyl chlorophenoxyisobutyrate (Atromid-S).
    Platt DS; Cockrill BL
    Biochem Pharmacol; 1966 Jul; 15(7):927-35. PubMed ID: 4381792
    [No Abstract]   [Full Text] [Related]  

  • 11. Degradation kinetics of liver catalase in rats treated with ethyl-alpha-p-chlorophenoxyisobutyrate.
    Chiga M; Reddy J; Svoboda D
    Lab Invest; 1971 Jul; 25(1):49-52. PubMed ID: 5555696
    [No Abstract]   [Full Text] [Related]  

  • 12. Morphological and biochemical changes in rat liver during the early stages of ethyl chlorophenoxyisobutyrate administration.
    Kaneko A; Sakamoto S; Morita M; Onoe T
    Tohoku J Exp Med; 1969 Sep; 99(1):81-101. PubMed ID: 4390771
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of ethyl p-chlorophenoxyisobutyrate (CPIB) upon establishment and progression of experimental atherosclerosis in rabbits.
    Kritchevsky D; Sallata P; Tepper SA
    J Atheroscler Res; 1968; 8(5):755-61. PubMed ID: 5688373
    [No Abstract]   [Full Text] [Related]  

  • 14. Lipid lowering influence of ethyl p-chlorophenoxyisobutyrate in liver of rats fed high fat diets.
    Kokatnur MG; Malcom GT
    Metabolism; 1970 Feb; 19(2):120-8. PubMed ID: 5410942
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of N-gamma-phenylpropyl-N-benzyloxy acetamide (W-1372) and of clofibrate on the lipids of normal and hypercholesteremic rats.
    Berger FM; Douglas JF; Lu GG; Ludwig BJ
    Proc Soc Exp Biol Med; 1969 Oct; 132(1):293-7. PubMed ID: 5344849
    [No Abstract]   [Full Text] [Related]  

  • 16. STUDIES WITH ETHYL CHLOROPHENOXYISOBUTYRATE (CLOFIBRATE).
    AZARNOFF DL; TUCKER DR; BARR GA
    Metabolism; 1965 Sep; 14():959-65. PubMed ID: 14327272
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum lipid responses to ethyl-p-chlorophenoxyisobutyrate with different dietary fats.
    Kokatnur MG; Malcom GT; Martinez RD
    Metabolism; 1969 Jan; 18(1):73-80. PubMed ID: 5764810
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological study of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminium. I. The effect of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminum on lipid metabolism in normal rats.
    Tomita T; Takeshita R; Nagakura T; Hayashi E
    Jpn J Pharmacol; 1973 Jun; 23(3):281-7. PubMed ID: 4541943
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of ethyl-p-chlorophenoxyisobutyrate, clofibrate, on the plasma and red blood cell free fatty acids of the rat.
    Cenedella RJ; Jarrell JJ; Saxe LH
    J Atheroscler Res; 1968; 8(6):903-11. PubMed ID: 5707796
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolism of hepatic and plasma triglycerides in rabbits given ethanol or ethionine.
    Bezman-Tarcher A; Nestel PJ; Felts JM; Havel RJ
    J Lipid Res; 1966 Mar; 7(2):248-57. PubMed ID: 5947039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.